SCHEMBL15519114

SCHEMBL15519114

O=C(O)CCc1ccn(C2CCCCO2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 1/20 0.43
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
KDM4E B2RXH2 5/20 0.37
ALDH1A1 P00352 4/20 0.37
GAA P10253 3/20 0.37
HPGD P15428 2/20 0.37
CASP1 P29466 2/20 0.37
HSD17B10 Q99714 2/20 0.37
GLA P06280 2/20 0.36
MEN1 O00255 1/20 0.36
CYP2C19 P33261 1/20 0.36
RECQL P46063 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CASP7 P55210 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
CYP4F2 P78329 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31338368 0.87 RXRA (0.45) CD274RXRARXRBRXRGMEN1
SCHEMBL21646747 0.84 CD274 (0.41) CD274RXRARXRBRXRGMEN1
SCHEMBL18483949 0.82 CD274 (0.43) CD274RXRARXRBRXRGALDH1A1
SCHEMBL15519027 0.81 CD274 (0.39) CD274RXRARXRBRXRGALDH1A1
SCHEMBL22381074 0.81 CD274 (0.39) CD274GAAMEN1CYP2C19KMT2A
SCHEMBL28361826 0.79 CD274 (0.41) CD274RXRARXRBRXRGMEN1
SCHEMBL22816839 0.79 CD274 (0.40) CD274KDM4EALDH1A1GAAHPGD
SCHEMBL15519361 0.79 MEN1 (0.38) CD274KDM4EALDH1A1GAAMEN1
SCHEMBL25232393 0.78 CD274 (0.40) CD274RXRARXRBRXRGALDH1A1
SCHEMBL18485036 0.78 CD274 (0.40) CD274RXRARXRBRXRGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140081025-A1 HETEROAROMATIC RING DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-03-20 US disclosed
US-20140081025-A1 HETEROAROMATIC RING DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-03-20 US disclosed
US-20140081025-A1 HETEROAROMATIC RING DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-03-20 US disclosed
EP-2708537-A1 HETEROAROMATIC RING DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2014-03-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140081025-A1 HETEROAROMATIC RING DERIVATIVE HCRTR2, HCRTR1, HTT CD274 611/4885RXRA 1208/4885RXRB 1620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.